How many times should I follow up with a Founder (after a demo)?

Don't follow a cold email the next morning. Give it 4 business days. Same day with the recap. A value bump 3 days later if they went quiet. After that, send a breakup note and archive it. A founder who wants it will answer a clean close more often than a fifth bump.

Should I mention a mutual connection in a cold email?

Only if the connection would be comfortable with it. Name-dropping someone who barely knows you can backfire. If you do mention them, say exactly how you know them in one clause and move on. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Should I include a recording in the demo follow-up?

If you recorded it and they agreed, yes, plus timestamps for the two parts they cared about. A raw 40-minute link with no map is homework. Add the three bullets they'd need to brief a colleague. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it okay to send this cold email on LinkedIn instead of email?

Yes if this founder is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals cold email?

Don't use consumer-startup slang. It's a credibility leak. Calling them a 'decision maker' or pitching like they're a Fortune 500 process. Don't send a 19-page deck that relitigates features they skipped. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Pharmaceuticals · Founder · After Demo

Cold Email Template for Pharmaceuticals Founder: After Demo

Use this cold email template when you're emailing a Founder in Pharmaceuticals (after a demo). They saw the product. Now they're comparing, forwarding, or quietly deciding it wasn't for them. Keep the note aligned with Human and specific. Peer to peer, not vendor to 'target.'

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this cold email work for a Pharmaceuticals Founder?

Make the first ask smaller than a 30-minute call.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a founder actually reads: Short, vivid, one proof point max.
Replay the two moments they leaned in, and the one concern they named.
Give them permission to say you're early.

When should I send this to a Pharmaceuticals Founder?

Don't follow a cold email the next morning. Give it 4 business days. Same day with the recap. A value bump 3 days later if they went quiet. For this combo, treat "Same day, then 3 days if silent" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max. If they named a board week or a freeze, believe it and leave a reopen date.

What this Founder actually cares about

A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. If your note would embarrass them in a team channel, rewrite it.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Proof that lands: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone human and specific.
Don't attach a deck on the first email.
Time it for Same day, then 3 days if silent. Same day with the recap. A value bump 3 days later if they went quiet.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after demo note?

Opening with your company story is how cold email dies.
Don't send a 19-page deck that relitigates features they skipped.
Don't use consumer-startup slang. It's a credibility leak.
Calling them a 'decision maker' or pitching like they're a Fortune 500 process.

How does this after demo scenario compare?

Dimension	For this template
Best send window	Same day, then 3 days if silent
Ideal length	Short, vivid, one proof point max.
Primary ask	a yes/no on timing, or a 15-minute working chat
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Human and specific. Peer to peer, not vendor to 'target.'
Unlike after meeting	They have product context now. Speak to what they saw, not to a generic intro.
Unlike after proposal	Pricing may not be on paper yet. Don't jump to 'ready to sign.'

What should I copy and send?

Copy-ready template

Subject

Idea for [Company Name]'s [pain]

Body

Hi [First Name],

Saw [trigger] and figured this might be on your plate.

I'm writing because a label update, a launch window, or a congress. I don't need a demo. I can send a 6-line teardown of how [Company Name] might approach follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick.

Answer the real objection and make internal forwarding easy.

Wrong person? Point me to whoever owns [pain].

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Name the situation and the business object, not your excitement. Something like "Idea for [Company Name]'s [pain]" outperforms "Just checking in" because a founder can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Related templates

Want a custom draft instead? Try the email generator.